A new study published in the journal Diabetes Technology & Therapeutics has evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Tirzepatide is approved for managing type 2 diabetes. It improves glucose control, facilitates weight loss, and improves cardiovascular disease outcomes.

Source: Medical Xpress